# Medpace Holdings (MEDP) — Analyst Forecast

MEDP · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/medp/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 2 | 12 | 2 | 16 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $492.00 | $626.88 | $700.00 | 8 |

Last price $628.60 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Barclays | Maintained | Equal-Weight | $625.00 |
| Oct 7, 2026 | Mizuho | Maintained | Outperform | $700.00 |
| Sep 30, 2026 | UBS | Upgraded | Sell → Neutral | $673.00 |
| Jul 24, 2026 | Baird | Maintained | Neutral | $624.00 |
| Jul 24, 2026 | RBC Capital | Maintained | Outperform | $692.00 |
| Jul 24, 2026 | TD Cowen | Maintained | Hold | $492.00 |
| Jul 24, 2026 | Truist Securities | Maintained | Hold | $609.00 |
| Jul 24, 2026 | BMO Capital | Maintained | Market Perform | $600.00 |
| Jul 24, 2026 | Mizuho | Maintained | Outperform | $665.00 |
| Jul 13, 2026 | Mizuho | Maintained | Outperform | $586.00 |
| Jul 8, 2026 | Baird | Downgraded | Outperform → Neutral | $547.00 |
| Jul 7, 2026 | Jefferies | Downgraded | Buy → Hold | $515.00 |
| Apr 24, 2026 | Baird | Maintained | Outperform | $477.00 |
| Apr 24, 2026 | RBC Capital | Maintained | Outperform | $484.00 |
| Apr 24, 2026 | BMO Capital | Maintained | Market Perform | $400.00 |
| Apr 24, 2026 | Barclays | Maintained | Equal-Weight | $450.00 |
| Mar 6, 2026 | Barclays | Upgraded | Underweight → Equal-Weight | $500.00 |
| Mar 3, 2026 | RBC Capital | Initiated Coverage | Outperform | $522.00 |
| Feb 18, 2026 | TD Cowen | Upgraded | Sell → Hold | $419.00 |
| Feb 13, 2026 | Jefferies | Upgraded | Hold → Buy | $560.00 |

## Frequently Asked Questions

### What is the price target for MEDP stock?

The average 12-month analyst price target for Medpace Holdings (MEDP) is $626.88, with a high estimate of $700.00 and a low of $492.00, across 8 analysts.

### Is MEDP a buy, sell, or hold?

Analysts covering Medpace Holdings currently average a Hold rating: 2 buy, 12 hold and 2 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for MEDP?

The average price target of $626.88 implies 0.27% downside from the last price of $628.60.

### What is the latest analyst rating on MEDP?

On Oct 7, 2026, Barclays maintained Medpace Holdings at Equal-Weight with a price target of $625.00.

## Similar Stocks

- [HIMS](https://www.lighthorse.io/tickers/hims) — Hims & Hers Health, Inc. Class A Common Stock
- [ELV](https://www.lighthorse.io/tickers/elv) — Elevance Health, Inc. Common Stock
- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock
- [IQV](https://www.lighthorse.io/tickers/iqv) — IQVIA Holdings, Inc. Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).